Recently launched Organon is the only company of its size focused exclusively on women’s health.
With an international footprint that serves people in more than 140 markets, Organon’s mission is to deliver impactful medicines and solutions for healthcare issues facing women in Sub-Saharan Africa.
“As a new healthcare company in South Africa our focus is on listening to South African women’s healthcare needs, and develop solutions tailored to their needs. With our global reach and local mindset, we know there is much we can do for women’s health in South Africa,” explains Organon South Africa and Sub-Saharan Africa Managing Director, Dr Abofele Khoele.
Organon will also focus on its important biosimilars business, focusing on oncology and inflammatory diseases, while maximizing the value of its trusted dermatology, pain, respiratory and cardiovascular portfolio in countries around the world where there is still great need for these treatments.
Dr Abofele Khoele joins Giselle Wertheim Aymes, Founder of World of Longevity, in The Business of Health studio.
About Dr Abofele Khoele
Experienced Executive Director with a demonstrated history of working in the pharmaceuticals industry. Skilled in Pharmaceutics, Business Planning, Coaching, Vaccines, and Oncology. Strong business development professional graduated from UCT Graduate School of Business.
Watch all episodes of The Business of Health here.